
Sign up to save your podcasts
Or
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage.
đź’Š Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
SOCIALS:
4.9
203203 ratings
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage.
đź’Š Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
SOCIALS:
1,172 Listeners
2,096 Listeners
333 Listeners
36 Listeners
497 Listeners
245 Listeners
1,546 Listeners
32 Listeners
358 Listeners
56 Listeners
50 Listeners
160 Listeners
143 Listeners
20 Listeners
98 Listeners